Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Conservation Biology?01:57

What is Conservation Biology?

24.5K
Conservation biology is a scientific field that focuses on the preservation of biodiversity in order to protect ecosystems while meeting the needs of the human population. Humans require properly functioning ecosystems to maintain our supply of natural resources, including food, medicines, and building materials.
24.5K
Therapeutic Index01:13

Therapeutic Index

7.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.0K
Biological Effects of Radiation02:59

Biological Effects of Radiation

18.1K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
18.1K
Synthetic Biology02:55

Synthetic Biology

5.6K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
5.6K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

678
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
678
Therapeutic Communication01:30

Therapeutic Communication

8.8K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioengineered 3D Human Trabecular Meshwork Models for Outflow Physiology and Glaucoma Research.

Bioengineering (Basel, Switzerland)·2026
Same author

Cryoelectrospun Elastin-Alginate Scaffolds Support In Vitro 3D Epithelial-Stromal Cocultures for Salivary Tissue Engineering.

Gels (Basel, Switzerland)·2025
Same author

Modulation of Antibody Glycosylation in Chinese Hamster Ovary Cells: Experimental and Computational Analyses Provide Mechanistic Insights.

Biotechnology journal·2025
Same author

Real-Time Monitoring of the Cytotoxic Effect of Oxygen-Sensitive Fluorescent Poly(styrene-maleic anhydride) Nanoparticles Using Electrical-Substrate Impedance Sensing.

ACS applied bio materials·2025
Same author

Stipulations of cell and gene therapy and the ties to biomanufacturing.

Biotechnology progress·2025
Same author

The 'Omics Revolution in CHO Biology: Roadmap to Improved CHO Productivity.

Methods in molecular biology (Clifton, N.J.)·2024
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Related Experiment Video

Updated: Feb 16, 2026

Microcontact Printing of Proteins for Cell Biology
09:21

Microcontact Printing of Proteins for Cell Biology

Published on: December 5, 2008

21.6K

Non-protein biologic therapeutics.

Susan T Sharfstein1

  • 1Colleges of Nanoscale Science and Engineering, SUNY Polytechnic Institute, 257 Fuller Road, Albany, NY 12203, United States.

Current Opinion in Biotechnology
|January 1, 2018
PubMed
Summary
This summary is machine-generated.

Non-protein biologics, including peptides and nucleic acids, are emerging as powerful new treatments for rare diseases and cancer. This review explores these advances and their manufacturing challenges.

More Related Videos

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.8K
Multimer-PAGE: A Method for Capturing and Resolving Protein Complexes in Biological Samples
07:40

Multimer-PAGE: A Method for Capturing and Resolving Protein Complexes in Biological Samples

Published on: May 5, 2017

12.1K

Related Experiment Videos

Last Updated: Feb 16, 2026

Microcontact Printing of Proteins for Cell Biology
09:21

Microcontact Printing of Proteins for Cell Biology

Published on: December 5, 2008

21.6K
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.8K
Multimer-PAGE: A Method for Capturing and Resolving Protein Complexes in Biological Samples
07:40

Multimer-PAGE: A Method for Capturing and Resolving Protein Complexes in Biological Samples

Published on: May 5, 2017

12.1K

Area of Science:

  • Biotechnology
  • Pharmacology
  • Therapeutics

Background:

  • Therapeutic proteins, like monoclonal antibodies, currently dominate the biologics market.
  • Non-protein biologics represent a rapidly growing area in clinical development and approved products.
  • These novel therapies offer new treatment options for previously untreatable conditions and targets.

Purpose of the Study:

  • To review recent advancements in non-protein therapeutic biologics.
  • To highlight novel treatment modalities and their applications.
  • To discuss manufacturing and commercialization challenges for these emerging therapies.

Main Methods:

  • Literature review of recent scientific publications and clinical trial data.
  • Analysis of approved non-protein biologic products.
  • Examination of manufacturing processes and market access strategies.

Main Results:

  • Significant progress has been made in peptide, nucleic acid, carbohydrate, vaccine, and cell-based therapies.
  • First-in-class non-protein biologics have been approved for rare genetic disorders and oncology.
  • These therapies offer novel mechanisms of action and address unmet medical needs.

Conclusions:

  • Non-protein biologics are expanding the therapeutic landscape beyond traditional proteins.
  • Further innovation in manufacturing and commercialization is crucial for broader patient access.
  • These therapies hold significant promise for treating complex and rare diseases.